• 1
    USRDS: United States Renal Data System Annual Data Report. Bethesda: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Division of Kidney Urologic and Hematologic Diseases, 2000:339348.
  • 2
    Foley RN, Murray AM, Li S, Herzog CA, McBean AM, Eggers PW, Collins AJ: Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998 to 1999. J Am Soc Nephrol16:489495, 2005
  • 3
    Murabito JM, Evans JC, Larson MG, Nieto K, Levy D, Wilson PWF: The ankle-brachial index in the elderly and risk of stroke, coronary disease, and death: the Framingham Study. Arch Intern Med163:19391942, 2003
  • 4
    Newman AB, Shemanski L, Manolio TA, Cushman M, Mittelmark M, Polak JF, Powe NR, Siscovick D: Ankle-arm index as a predictor of cardiovascular disease and mortality in the Cardiovascular Health Study: the Cardiovascular Health Study Group. Arterioscler Thromb Vasc Biol19:538545, 1999
  • 5
    Criqui MH, Langer RD, Fronek A, Feigelson HS, Klauber MR, McCann TJ, Browner D: Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med326:381386, 1992
  • 6
    Guerin AP, Pannier B, Marchais SJ, London GM: Cardiovascular disease in the dialysis population: prognostic significance of arterial disorders. Curr Opin Nephrol Hypertens15:105110, 2006
  • 7
    Robinson RF, Nahata MC, Sparks E, Robinson RF, Nahata MC, Sparks E, Daniels C, Batisky DL, Hayes JR, Mahan JD: Abnormal left ventricular mass and aortic distensibility in pediatric dialysis patients. Pediatr Nephrol20:6468, 2005
  • 8
    Goodman WG, Goldin J, Kuizon BD: Coronary artery calcification in young adults with end-stage renal disease who are undergoing hemodialysis. N Engl J Med342:14781483, 2000
  • 9
    Block GA, Klassen PS, Lazarus JM, Ofsthun N, Lowrie EG, Chertow GM: Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol15:22082218, 2004
  • 10
    Young EW, Akiba T, Albert JM, McCarthy JT, Kerr PG, Mendelssohn DC, Jadoul M: Magnitude and impact of abnormal mineral metabolism in hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis44(Suppl. 2):3438, 2004
  • 11
    Cooper BA, Penne EL, Bartlett LH, Pollack CA: Protein malnutrition and hypoalbuminemia as predictors of vascular events and mortality in ESRD. Am J Kidney Dis43:6166, 2004
  • 12
    Hiatt WR: Medical treatment of peripheral arterial disease and claudication. N Engl J Med344:16081621, 2001
  • 13
    Braunwald E, Zipes DP, Libby P: Heart Disease: A Textbook of Cardiovascular Medicine. Philadelphia PA: Saunders, 2001
  • 14
    Hirsch AT, Criqui MH, Treat-Jacobson D, Regensteiner JG, Creager MA, Olin JW, Krook SH, Hunninghake DB, Comerota AJ, Walsh ME, McDermott MM, Hiatt WR: Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA286:13171324, 2001
  • 15
    Hirsch AT, Hiatt WR; PARTNERS Steering Committee: PAD awareness, risk, and treatment: new resources for survival – the USA PARTNERS program. Vasc Med6(3 Suppl.):912, 2001
  • 16
    Selvin E, Erlinger TP: Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999-2000. Circulation2004;110(6):738743.
  • 17
    Lamar WV, Casper M, Greenlund K: Prevalence of lower extremity arterial disease defined by the ankle-brachial index among American Indians: the Inter-Tribal Heart Project. Ethn Dis12:S1S7, 2002
  • 18
    Leskinen Y, Salenius JP, Lehtimaki T: The prevalence of peripheral arterial disease and medial arterial calcification in patients with chronic renal failure: requirements for diagnostics. Am J Kidney Dis40:472479, 2002
  • 19
    Newman AB, Siscovick DS, Manolio TA: Ankle-arm index as a marker of atherosclerosis in the Cardiovascular Health Study: cardiovascular Heart Study (CHS) Collaborative Research Group. Circulation88:837845, 1993
  • 20
    Eggers PW, Gohdes D, Pugh J: Nontraumatic lower extremity amputations in the Medicare end-stage renal disease population. Kidney Int56:15241533, 1999
  • 21
    DeLoach SS, Mohler ER: Peripheral arterial disease: a guide for nephrologists. Clin J Am Soc Nephrol2:839846, 2007
  • 22
    O’Hare AM, Glidden DV, Fox CS, Hsu C-Y: High prevalence of peripheral arterial disease in persons with renal insufficiency. Circulation109:320323, 2004
  • 23
    O’Hare AM, Hsu C, Bacchetti P, Johansen KL: Peripheral vascular disease risk factors among patients undergoing hemodialysis. J Am Soc Nephrol13:497503, 2002
  • 24
    Mcdermott MM, Greenland P, Liu K, Guralnik JM, Criqui MH, Dolan NC, Chan C, Celic L, Pearce WH, Schneider JR, Sharma L, Clark E, Gibson D, Martin GJ: Leg symptoms in peripheral arterial disease: associated clinical characteristics and functional impairment. JAMA286:15991606, 2001
  • 25
    McGee SR, Boyko EJ: Physical examination and chronic lower-extremity ischemia: a critical review. Arch Intern Med158:13571364, 1998
  • 26
    McDermott MM, Criqui MH, Liu K, Guralnik JM, Greenland P, Martin GJ, Pearce W: Lower ankle/brachial index, as calculated by averaging the dorsalis pedis and posterior tibial arterial pressures, and association with leg functioning in peripheral arterial disease. J Vasc Surg32(6):11641171, 2000
  • 27
    Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG, Bell K, Caporusso J, Durand-Zaleski I, Komori K, Lammer J, Liapis C, Novo S, Razavi M, Robbs J, Schaper N, Shigematsu H, Sapoval M, White C, White J, Clement D, Creager M, Jaff M, Mohler E III, Rutherford RB, Sheehan P, Sillesen H, Rosenfield K: Inter-society consensus for the management of peripheral arterial disease (TASC II). Eur J Vasc Endovasc Surg33(Suppl. 1):S1S75, 2007
  • 28
    National Kidney Foundation: K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients. Am J Kidney Dis45:S1S153, 2005
  • 29
    Rutherford RB, Baker JD, Ernst C, Johnston KW, Porter JM, Ahn S, Jones DN: Recommended standards for reports dealing with lower extremity ischemia: revised version. J Vasc Surg26:517538, 1997
  • 30
    Heald CL, Fowkes FG, Murray GD, Price JF: Ankle Brachial Index Collaboration: risk of mortality and cardiovascular disease associated with the ankle-brachial index: systematic review. Atherosclerosis189:6169, 2006
  • 31
    McLafferty RB, Moneta GL, Taylor LM Jr, Porter JM: Ability of ankle-brachial index to detect lower-extremity atherosclerotic disease progression. Arch Surg132:836840, 1997
  • 32
    Okamoto K, Oka M, Maesato K, Ikee R, Mano T, Moriya H, Ohtake T, Kobayashi S: Peripheral arterial occlusive disease is more prevalent in patients with hemodialysis: comparison with the findings of multidetector-row computed tomography. Am J Kidney Dis48:269276, 2006
  • 33
    Ogata H, Kumata-Maeta C, Shishido K, Mizobuchi M, Yamamoto M, Koiwa F, Kinugasa E, Akizawa T: Detection of peripheral artery disease by duplex ultrasonography among hemodialysis patients. Clin J Am Soc Nephrol5(12):21992206, 2010
  • 34
    Haemel AK, Sadowski EA, Shafer MM, Djamali A: Update on nephrogenic systemic fibrosis: are we making progress?Int J Dermatol50(6):659666, 2011
  • 35
    Li JH, He NS: Prevention of iodinated contrast-induced nephropathy. Chin Med J (Engl)124(23):40794082, 2011
  • 36
    Clagett GP, Sobel M, Jackson MR: Antithrombotic therapy in peripheral arterial occlusive disease. The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest126:609S626S, 2004
  • 37
    Hirsch AT: ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines. Circulation113:e463, 2005
  • 38
    Norgren L, Hiatt WR, Dormandy JA, Nehler KAH, Fowkes FGR: Inter-Society consensus for the management of peripheral arterial disease (TASC II). J Vasc Surg45(Suppl. 1):S5S67, 2007
  • 39
    Momsen AH, Jensen MB, Norager CB, Madsen MR, Vestersgaard-Andersen T, Lindholt JS: Therapy for improving walking distance in intermittent claudication: a systematic review and meta-analysis of robust randomised controlled studies. Eur J Vasc Endovasc Surg38:463474, 2009
  • 40
    Beebe HG, Dawson DL, Cutler BS: A new pharmacological treatment for intermittent claudication: results of a randomized, multicenter trial. Arch Intern Med159:20412050, 1999
  • 41
    Mohler ER, Beebe HG, Salles-Cuhna S: Effects of cilostazol on resting ankle pressures and exercise-induced ischemia in patients with intermittent claudication. Vasc Med6:151156, 2001
  • 42
    Reilly MP, Mohler ER: Cilostazol: treatment of intermittent claudication. Ann Pharmacother35:4856, 2001
  • 43
    Dormandy JA, Rutherford RB, for the Trans Atlantic Inter-Society Consensus (TASC) Working Group: Management of peripheral arterial disease (PAD). J Vasc Surg31:S1S296, 2000
  • 44
    O’Hare AM, Sidawy AN, Feinglass J, Merine KM, Daley J, Khuri S, Henderson WG, Johansen K: Influence of renal insufficiency on limb loss and mortality after initial lower extremity surgical revascularization. J Vasc Surg39:709716, 2004
  • 45
    O’Hare AM, Feinglass J, Sidawy AN, Bacchetti P, Rodriguez RA, Daley J, Khuri S, Henderson WG, Johansen K: Impact of renal insufficiency on short-term morbidity and mortality after lower extremity revascularization: data from the Department of Veterans Affairs’ National Surgical Quality Improvement Program. J Am Soc Nephrol14:12871295, 2003
  • 46
    Jaar BG, Astor BC, Berns JS, Powe NR: Predictors of amputation and survival following lower extremity revascularization in hemodialysis patients. Kidney Int65:613620, 2004
  • 47
    Sadowski EA, Bennett LK, Chan MR, Wentland AL, Garrett AL, Garrett RW, Djamali A: Nephrogenic systemic fibrosis: risk factors and incidence estimation. Radiology243:148157, 2007
  • 48
    Yevzlin AS, Schoenkerman AB, Gimelli G, Asif A: Arterial interventions in arteriovenous access and chronic kidney disease: a role for interventional nephrologists. Semin Dial22(5):545556, 2009
  • 49
    Hawkins IF Jr, Wilcox CS, Kerns SR, Sabatelli FW: CO2 digital angiography: a safer contrast agent for renal vascular imaging?Am J Kidney Dis24:685694, 1994